The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8'-methyl-11'-(2-(methylthio)phenyl)-4',5',10',11'-tetrahydrospiro[cyclopentane-1,3'-dibenzo[b,e][1,4]diazepin]-1'(2'H)-one ID: ALA560655
Max Phase: Preclinical
Molecular Formula: C25H28N2OS
Molecular Weight: 404.58
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CSc1ccccc1C1Nc2cc(C)ccc2NC2=C1C(=O)CC1(CCCC1)C2
Standard InChI: InChI=1S/C25H28N2OS/c1-16-9-10-18-19(13-16)27-24(17-7-3-4-8-22(17)29-2)23-20(26-18)14-25(15-21(23)28)11-5-6-12-25/h3-4,7-10,13,24,26-27H,5-6,11-12,14-15H2,1-2H3
Standard InChI Key: JAGBDJWFJCMSEX-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
8.8745 -5.9338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6216 -6.2835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1852 -5.6810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7863 -4.9589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9763 -5.1151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7274 -8.2993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8957 -9.1069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2804 -9.6565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4968 -9.3984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3285 -8.5908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9438 -8.0412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7755 -7.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8107 -5.3801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9748 -7.0347 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4458 -5.9066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4301 -6.7315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1367 -7.1575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8588 -6.7586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1680 -5.5078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6310 -6.2848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0030 -5.5484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5513 -4.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7276 -4.9041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3556 -5.6405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8073 -6.3308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5319 -5.6865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1210 -7.9823 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5449 -8.3327 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.3766 -7.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20 14 1 0
16 12 1 0
14 12 1 0
15 16 2 0
2 3 1 0
7 8 1 0
3 4 1 0
8 9 2 0
4 5 1 0
15 19 1 0
16 17 1 0
17 18 1 0
18 1 1 0
1 19 1 0
9 10 1 0
5 1 1 0
20 21 2 0
10 11 2 0
21 22 1 0
11 6 1 0
22 23 2 0
1 2 1 0
23 24 1 0
11 12 1 0
24 25 2 0
25 20 1 0
24 26 1 0
21 13 1 0
17 27 2 0
13 15 1 0
10 28 1 0
6 7 2 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 404.58Molecular Weight (Monoisotopic): 404.1922AlogP: 6.47#Rotatable Bonds: 2Polar Surface Area: 41.13Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.33CX Basic pKa: 2.60CX LogP: 5.14CX LogD: 5.13Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.56Np Likeness Score: -0.60
References 1. Fu J, Shuttleworth SJ, Connors RV, Chai A, Coward P.. (2009) Discovery and optimization of a novel Neuromedin B receptor antagonist., 19 (15): [PMID:19553112 ] [10.1016/j.bmcl.2009.05.124 ]